• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • Comprehensive Eye Exams
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Topcon acquires Henson perimetry products


Leading perimetry screening devices added to company’s portfolio

Topcon Healthcare has acquired the Henson line of perimetry products from Elektron Eye Technology. As part of the acquisition, members of the Elektron staff will transition to Topcon. Product manufacturing will continue to operate from the UK.

Deal terms were not disclosed, but products including Henson 9000 and 7000 are within the range of products being acquired, according to the company.

The optical perimeter, Henson 9000, is used for early glaucoma detection and ongoing monitoring of established loss. Henson 7000 is an affordable, lightweight, mobile perimeter designed to screen for suprathreshold glaucoma in the central field.

“The acquisition of the Henson range of products will provide us with the opportunity to strategically develop this area of the company’s product portfolio,” said Topcon Healthcare Marketing and Product Design Global VP John Trefethen in a statement.

Related: GenSight Biologics reports results of Lumevoq treatment on LHON patients

Related Videos
Jacobi Cleaver, OD, FAAO
Jade Coats, OD, overviews a lecture on ocular pain and patient care
Jade Coats, OD, outlines two poster presentations she gave on a novel lipid-containing eye drop at the AOA Optometry's Meeting
Adam Alexander, OD, chats with Optometry Times about his AOA e-poster presentation on Miebo
Lorraine Provencher, MD, presenting slides
Megan Cavet, PhD
Nazlee Zebardast, MD, MSc, overviews her ARVO 2024 presentations on glaucoma and polygenic risk scores
© 2024 MJH Life Sciences

All rights reserved.